Isentress (Raltegravir)
| Brand Name: |
Isentress |
| Generic Name: |
Raltegravir, MK-0518 |
| Adult Single Dose: |
One 400-mg tablet twice daily |
| Food & Liquid Restrictions: |
None |
| Drug Class: |
Integrase Inhibitor |
|
|
|
The Basics
- An Overview of Isentress (Raltegravir, MK-0518) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health
- Isentress (Raltegravir, MK-0518) Patient Product Information (PDF) (October 2009)
From Merck & Co., Inc.
- Patient Information About Isentress (Raltegravir, MK-0518) (PDF) (October 2009)
From Merck & Co., Inc.
- FDA Approves Expanded Use of HIV Drug (July 10, 2009)
In Kaiser Daily U.S. HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- HIV/AIDS Update: Isentress (Raltegravir) Indication Extended for the Treatment of HIV-1 Infection in Treatment-Naive Patients (July 9, 2009)
From U.S. Food and Drug Administration
- Raltegravir (Isentress) (June 12, 2009)
To read PDF, click here
From AIDS InfoNet
- Isentress (March/April 2009)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
- HIV/AIDS Update: Traditional Approval of Isentress (raltegravir) (February 5, 2009)
From U.S. Food and Drug Administration
- Characteristics of Fusion and Integrase Inhibitors, and CCR5 Antagonists (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents. For the full guidelines, click here (PDF).
From AIDSinfo
- Comparing Two Integrase Inhibitors (September/October 2008)
The first head-to-head study comparing raltegravir and elvitegravir.
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
- Letter Sent by Merck to the Fair Pricing Coalition Announcing ADAP Price Freeze of Isentress (PDF) (August 1, 2008)
From Merck & Co., Inc.
- Isentress (Raltegravir) (January 8, 2008)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
- Mr. Sharp Goes to Washington (November/December 2007)
Advocating for a new drug before the FDA.
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
- How Isentress Works: An Interview With David Wohl, M.D. (Part II) (October 23, 2007)
A detailed look at how Isentress works.
From The Body
- The Bottom Line on Isentress: An Interview With David Wohl, M.D. (Part I) (October 23, 2007)
An overview of Isentress.
From The Body
- Project Inform Reacts to Approval, Pricing of Isentress (October 15, 2007)
From Project Inform
- FDA Approval of Isentress (Raltegravir) (October 12, 2007)
From U.S. Food and Drug Administration
- Isentress (Raltegravir) Pricing: Community Sign-On Letter (October 11, 2007)
In AIDS Treatment News, from AIDS Treatment News
|
|
Advertisement
|
E-Mail
Glossary
Share
